MetaCap

Jade Biosciences Insider Trades

NASDAQ: JBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

14.39+0.24 (+1.70%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Jade Biosciences insider activity

Over the last 12 months, Jade Biosciences insiders reported 4 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows King Andrew James (See Remarks) reporting a transaction in 41,250 shares on Feb 12, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put JBIO's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

JBIO insider transactions

Jade Biosciences insider transactions
DateInsiderTypeSharesValueFiling
Feb 12, 2026Frohlich TomChief Executive OfficerAward78,750—Form 4
Feb 12, 2026Balta ElizabethSee RemarksAward28,125—Form 4
Feb 12, 2026Dahms Bradford D.Chief Financial OfficerAward37,813—Form 4
Feb 12, 2026King Andrew JamesSee RemarksAward41,250—Form 4
Oct 6, 2025Fairmount Funds Management LLC & Fairmount Healthcare Fund II L.P. & Fairmount Healthcare Co-Invest IV L.P. & Kiselak Tomas & Harwin Peter EvanDirectorAward1,333,126$12.18MForm 4
May 16, 2025Frohlich TomChief Executive OfficerBuy6,000$44.40KForm 4
Apr 28, 2025RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M.10% Ownerother1,062,326—Form 4
Aug 1, 2024Dake Benjamin TSEE REMARKSOption exercise1,507$2.62KForm 4
Jul 31, 2024Dake Benjamin TSEE REMARKSOption exercise11,454$19.93KForm 4
Jun 17, 2024RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund, L.P. & Kolchinsky Peter & Shah Rajeev M.DirectorBuy928,110$1.55MForm 4
Jun 14, 2024Eldridge George ASEE REMARKSSale15,000$375.45KForm 4
Jun 14, 2024Eldridge George ASEE REMARKSOption exercise15,000$32.10KForm 4
Jun 14, 2024Verwijs MarinusCHIEF TECHNICAL OFFICERSale10,600$265.00KForm 4
Jun 14, 2024Verwijs MarinusCHIEF TECHNICAL OFFICEROption exercise10,600$154.65KForm 4
Jun 13, 2024Gillies HunterCHIEF MEDICAL OFFICERSale6,000$147.00KForm 4
Jun 13, 2024Gillies HunterCHIEF MEDICAL OFFICEROption exercise6,000$12.84KForm 4
May 17, 2024Gillies HunterCHIEF MEDICAL OFFICERSale86$1.88KForm 4
May 17, 2024Gillies HunterCHIEF MEDICAL OFFICERSale3,914$82.45KForm 4
May 17, 2024Gillies HunterCHIEF MEDICAL OFFICEROption exercise4,000$8.56KForm 4
May 16, 2024NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERSale1,293$28.35KForm 4
May 16, 2024NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERSale8,707$187.41KForm 4
May 16, 2024NOYES TIMOTHY PCHIEF EXECUTIVE OFFICEROption exercise10,000$21.40KForm 4
May 2, 2024Verwijs MarinusCHIEF TECHNICAL OFFICERSale1,981$41.63KForm 4
May 1, 2024NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERSale1,357$27.02KForm 4
May 1, 2024NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERSale965$20.14KForm 4
May 1, 2024NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERSale9,035$183.79KForm 4
May 1, 2024NOYES TIMOTHY PCHIEF EXECUTIVE OFFICEROption exercise10,000$21.40KForm 4
Apr 17, 2024Gillies HunterCHIEF MEDICAL OFFICERSale311$7.25KForm 4
Apr 17, 2024Gillies HunterCHIEF MEDICAL OFFICERSale3,689$82.27KForm 4
Apr 17, 2024Gillies HunterCHIEF MEDICAL OFFICEROption exercise4,000$6.96KForm 4
Apr 17, 2024Dake Benjamin TSEE REMARKSSale68$1.63KForm 4
Apr 17, 2024Dake Benjamin TSEE REMARKSSale338$7.83KForm 4
Apr 17, 2024Dake Benjamin TSEE REMARKSSale6,447$143.87KForm 4
Apr 17, 2024Dake Benjamin TSEE REMARKSOption exercise6,853$14.67KForm 4
Apr 16, 2024NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERSale5,509$137.41KForm 4
Apr 16, 2024NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERSale4,491$109.56KForm 4
Apr 16, 2024NOYES TIMOTHY PCHIEF EXECUTIVE OFFICEROption exercise10,000$21.40KForm 4
Apr 10, 2024Eldridge George ASEE REMARKSSale771$21.25KForm 4
Apr 10, 2024Eldridge George ASEE REMARKSSale6,729$180.14KForm 4
Apr 10, 2024Eldridge George ASEE REMARKSOption exercise7,500$16.05KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related